首页 | 本学科首页   官方微博 | 高级检索  
检索        

喷昔洛韦在健康受试者的耐受性
引用本文:周颖,孙培红,赵侠,刘玉旺,赵东方,崔一民,孙忠民,朱学骏,杨海珍.喷昔洛韦在健康受试者的耐受性[J].中国临床药理学杂志,2004,20(5):351-353.
作者姓名:周颖  孙培红  赵侠  刘玉旺  赵东方  崔一民  孙忠民  朱学骏  杨海珍
作者单位:1. 北京大学,第一医院,药剂科,北京,100034
2. 北京大学,第一医院,皮肤科,北京,100034
摘    要:目的 评价单次注射喷昔洛韦在健康志愿者中的安全性和耐受性。方法 选择27名20~40岁健康志愿者,随机分配至4个剂量组,观察志愿者临床体征及各种生化指标。结果 在单次注射125,250,375和500 mg喷昔洛韦时,用药后24,72 h受试者的体征及实验室检查结果与给药前比较没有显著性差异。结论 受试者对喷昔洛韦具有很好的耐受性,推荐临床剂量1次 125 ~ 500 mg 可以接受。

关 键 词:喷昔洛韦  单次给药  耐受性
文章编号:1001-6821(2004)05-0351-03

Toleration of penciclovir in healthy volunteers
ZHOU Ying,SUN Pei-hong,ZHAO Xia,LIU Yu-wang,ZHAO Dong-fang,CUI Yi-min,SUN Zhong-min,ZHU Xue-jun,YANG Hai-zhen.Toleration of penciclovir in healthy volunteers[J].The Chinese Journal of Clinical Pharmacology,2004,20(5):351-353.
Authors:ZHOU Ying  SUN Pei-hong  ZHAO Xia  LIU Yu-wang  ZHAO Dong-fang  CUI Yi-min  SUN Zhong-min  ZHU Xue-jun  YANG Hai-zhen
Institution:ZHOU Ying1,SUN Pei-hong1,ZHAO Xia1,LIU Yu-wang1,ZHAO Dong-fang1,CUI Yi-min1,SUN Zhong-min1,ZHU Xue-jun2,YANG Hai-zhen2
Abstract:Objective To assess the safety and toleration of penciclovir in healthyvolunteers. Methods The healthy subjects aged 20~40 years were screened to ensurethat 27 subjects completed the study and were allocated to group of different dose,then the clinical symptoms, vital sign and laboratory tests were observed pre-doseand pro-dose .Results Single oral taking 125, 250 ,375 and 500 mg of penciclovir didnot affect the vital signs of the subjects. There were no abnormal changes in thelaboratory examinations pre dosing and 24 and 72h after administration. ConlusionThe results suggested that the tolerence of penciclovir is good, and 125 to 500 mgof penciclovir at a time recommended for clinical use is acceptable.
Keywords:penciclovir  single-dose  tolerance
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号